Unveiling ZIF‑8 Nucleation Mechanisms through Molecular Simulation: Role of Temperature, Solvent, and Reactant Concentration gan Sahar Andarzi Gargari (22675844)

Pynciau:

Unveiling ZIF‑8 Nucleation Mechanisms through Molecular Simulation: Role of Temperature, Solvent, and Reactant Concentration gan Sahar Andarzi Gargari (22675844)

Pynciau:

Effects of the weather on the probability of having an abnormally low score (cognitive outcomes) OR: gan Jason Shourick (11436869)

Pynciau:

Occupational and other individual exposure factors. gan Paul Le Turnier (7829654)

Pynciau:

Flow chart of participants in leptospirosis serological survey. gan Paul Le Turnier (7829654)

Pynciau:

Water collection sources and usages. gan Paul Le Turnier (7829654)

Pynciau:

Effects of the weather on the probability of having an abnormally low score (functional and physical outcomes): gan Jason Shourick (11436869)

Pynciau:

Microscopic agglutination test results. gan Paul Le Turnier (7829654)

Pynciau:

Flow Chart. gan Jason Shourick (11436869)

Pynciau:

Description of the weather on visit days. gan Jason Shourick (11436869)

Pynciau:

Seepage Behavior of CO₂ Hydrate Bearing Sands Regulated by l‑Methionine: Insights into Hydrate-Based CO₂ Sequestration gan Yang Li (7082)

Pynciau:

Sociodemographic data and residence characteristics. gan Paul Le Turnier (7829654)

Pynciau:

Description of participants at baseline. gan Jason Shourick (11436869)

Pynciau:

Association of a COVID-19 diagnosis with adverse events, cohort design, follow-up starting on the day after time 0. gan Shelby S. Fisher (22676406)

Pynciau:

Association of a COVID-19 diagnosis with adverse events, SCRI design, marketscan and medicare, follow-up starting on the day after time 0. gan Shelby S. Fisher (22676406)

Pynciau:

Eligibility assessment, covariate assessment, and follow-up windows relative to time 0 for the cohort design. gan Shelby S. Fisher (22676406)

Pynciau:

Estimated Association of a COVID-19 Diagnosis With Neurologic or Immune-Mediated Outcomes: Analysis Starting Follow-Up on the Day After Time 0. gan Shelby S. Fisher (22676406)

Pynciau:

Characteristics of included individuals for SCRI and cohort analyses. gan Shelby S. Fisher (22676406)

Pynciau:

Analysis set for each outcome and definition. gan Shelby S. Fisher (22676406)

Pynciau:

Eligibility Assessment, Covariate Assessment, Risk Windows, and Reference Windows Relative to Time 0 for the Self-Controlled Risk Interval Design. gan Shelby S. Fisher (22676406)

Pynciau: